Fetomaternal Outcome in Gestational Diabetes Mellitus
A recent retrospective analytical study evaluated the risk factors and feto-maternal outcomes in mothers with Gestational diabetes mellitus. It included Antenatal patients beyond 22 weeks of gestation with deranged sugars. It made the diagnosis of GDM by Oral Glucose Tolerance test or by FBS, PPBS values.
The study gave diabetic mothers- a diabetic diet and initiated insulin or oral hypoglycaemic agents according to their requirements and monitored. It then compared the risk factors and effects on maternal and fetal outcomes among the groups.
The study found-
- A higher incidence of Gestational diabetes mellitus (68%) in mothers > 30 years, with increased parity and increased pre-pregnancy BMI.
- More incidence of being born preterm (32%) and increased incidence of delivery by Caesarian Section (60%) in the babies born to GDM mothers.
- A higher mean birth weight (3.43 kg) in GDM babies and a higher incidence of IUFD in mothers of GDM.
- Significantly higher feto-maternal morbidity in patients with GDM.
This study found significant feto-maternal morbidity in patients with gestational diabetes mellitus. Hence, early detection by screening and timely intervention will help enhance the feto-maternal outcome.
Rajshree D, Adithi JP. Retrospective Study on Fetomaternal Outcome in Gestational Diabetes Mellitus. J Gynecol 2021, 6(4): 000225.
IJCP Editorial Team
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
More FAQs by IJCP Editorial Team
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article